Literature DB >> 27798766

A comprehensive insight on ocular pharmacokinetics.

Vibhuti Agrahari1, Abhirup Mandal1, Vivek Agrahari1,2, Hoang M Trinh1, Mary Joseph1, Animikh Ray1, Hicheme Hadji3, Ranjana Mitra1, Dhananjay Pal1, Ashim K Mitra4.   

Abstract

The eye is a distinctive organ with protective anatomy and physiology. Several pharmacokinetics compartment models of ocular drug delivery have been developed for describing the absorption, distribution, and elimination of ocular drugs in the eye. Determining pharmacokinetics parameters in ocular tissues is a major challenge because of the complex anatomy and dynamic physiological barrier of the eye. In this review, pharmacokinetics of these compartments exploring different drugs, delivery systems, and routes of administration is discussed including factors affecting intraocular bioavailability. Factors such as precorneal fluid drainage, drug binding to tear proteins, systemic drug absorption, corneal factors, melanin binding, and drug metabolism render ocular delivery challenging and are elaborated in this manuscript. Several compartment models are discussed; these are developed in ocular drug delivery to study the pharmacokinetics parameters. There are several transporters present in both anterior and posterior segments of the eye which play a significant role in ocular pharmacokinetics and are summarized briefly. Moreover, several ocular pharmacokinetics animal models and relevant studies are reviewed and discussed in addition to the pharmacokinetics of various ocular formulations.

Entities:  

Keywords:  Animal models; Anterior chamber; Compartment models; Ocular pharmacokinetics; Posterior chamber; Simulation study; Transporter

Mesh:

Substances:

Year:  2016        PMID: 27798766      PMCID: PMC5319401          DOI: 10.1007/s13346-016-0339-2

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  80 in total

1.  Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.

Authors:  Claudia Di Tommaso; Jean-Louis Bourges; Fatemeh Valamanesh; Gregory Trubitsyn; Alicia Torriglia; Jean-Claude Jeanny; Francine Behar-Cohen; Robert Gurny; Michael Möller
Journal:  Eur J Pharm Biopharm       Date:  2012-03-16       Impact factor: 5.571

Review 2.  Challenges and obstacles of ocular pharmacokinetics and drug delivery.

Authors:  Arto Urtti
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

Review 3.  Drug metabolism and pharmacokinetics.

Authors:  Margherita Strolin Benedetti; Rhys Whomsley; Italo Poggesi; Willi Cawello; François-Xavier Mathy; Marie-Laure Delporte; Peggy Papeleu; Jean-Baptiste Watelet
Journal:  Drug Metab Rev       Date:  2009       Impact factor: 4.518

Review 4.  Undefined role of mucus as a barrier in ocular drug delivery.

Authors:  Marika Ruponen; Arto Urtti
Journal:  Eur J Pharm Biopharm       Date:  2015-03-12       Impact factor: 5.571

5.  Stroke risk factors and subtypes in different age groups: a hospital-based study.

Authors:  Chih-Ying Wu; Hung-Ming Wu; Jiann-Der Lee; Hsu-Huei Weng
Journal:  Neurol India       Date:  2010 Nov-Dec       Impact factor: 2.117

6.  Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.

Authors:  Banmeet S Anand; Suresh Katragadda; Yasser E Nashed; Ashim K Mitra
Journal:  Curr Eye Res       Date:  2004 Aug-Sep       Impact factor: 2.424

Review 7.  Relevance of drug-melanin interactions to ocular pharmacology and toxicology.

Authors:  M M Salazar-Bookaman; I Wainer; P N Patil
Journal:  J Ocul Pharmacol       Date:  1994

Review 8.  Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.

Authors:  Eugene W M Ng; David T Shima; Perry Calias; Emmett T Cunningham; David R Guyer; Anthony P Adamis
Journal:  Nat Rev Drug Discov       Date:  2006-02       Impact factor: 84.694

Review 9.  Recent perspectives in ocular drug delivery.

Authors:  Ripal Gaudana; J Jwala; Sai H S Boddu; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

10.  Treatment of chronic dry eye: focus on cyclosporine.

Authors:  George D Kymionis; Dimitrios I Bouzoukis; Vassilios F Diakonis; Charalambos Siganos
Journal:  Clin Ophthalmol       Date:  2008-12
View more
  64 in total

1.  Noninvasive Monitoring of Choroid-Retina Autofluorescence and Intravitreal Nanoparticle Disposition in Royal College of Surgeon Rats of Different Ages and Retinal Thinning.

Authors:  Madhoosudan A Patil; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2020-06-18       Impact factor: 2.671

2.  Nanoparticles in thermosensitive gel based composite nanosystem for ocular diseases.

Authors:  Vibhuti Agrahari; Sulabh P Patel; Nikhil Dhall; Zach Aulgur; Siddhant Thukral; Xiaoyan Yang; Ryan Conley; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

Review 3.  Challenges and opportunities for drug delivery to the posterior of the eye.

Authors:  Fernando J Cabrera; Daniel C Wang; Kartik Reddy; Ghanashyam Acharya; Crystal S Shin
Journal:  Drug Discov Today       Date:  2019-06-05       Impact factor: 7.851

4.  Bioequivalence Study Methods with Pharmacokinetic Endpoints for Topical Ophthalmic Corticosteroid Suspensions and Effects of Subject Demographics.

Authors:  Yoriko Harigaya; Xiaojian Jiang; Hongling Zhang; Parthapratim Chandaroy; Ethan M Stier; Yuzhuo Pan
Journal:  Pharm Res       Date:  2018-11-15       Impact factor: 4.200

Review 5.  Advances and limitations of drug delivery systems formulated as eye drops.

Authors:  Clotilde Jumelle; Shima Gholizadeh; Nasim Annabi; Reza Dana
Journal:  J Control Release       Date:  2020-02-03       Impact factor: 9.776

Review 6.  Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.

Authors:  Mauro Sousa de Almeida; Eva Susnik; Barbara Drasler; Patricia Taladriz-Blanco; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Chem Soc Rev       Date:  2021-03-05       Impact factor: 54.564

7.  Delivery of Antisense Oligonucleotides to the Cornea.

Authors:  Viet Q Chau; Jiaxin Hu; Xin Gong; John D Hulleman; Rafael L Ufret-Vincenty; Frank Rigo; Thahza P Prakash; David R Corey; V Vinod Mootha
Journal:  Nucleic Acid Ther       Date:  2020-03-23       Impact factor: 5.486

Review 8.  Principles of pharmacology in the eye.

Authors:  Sahar Awwad; Abeer H A Mohamed Ahmed; Garima Sharma; Jacob S Heng; Peng T Khaw; Steve Brocchini; Alastair Lockwood
Journal:  Br J Pharmacol       Date:  2017-10-10       Impact factor: 8.739

9.  Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies.

Authors:  Rakhee Kapadia; Kinjal Parikh; Mahendra Jain; Krutika Sawant
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

Review 10.  Antimicrobial nanomedicine for ocular bacterial and fungal infection.

Authors:  Wenjie Fan; Haijie Han; Yaoyao Chen; Xiaobo Zhang; Yifan Gao; Su Li; Qiao Jin; Jian Ji; Ke Yao
Journal:  Drug Deliv Transl Res       Date:  2021-04-11       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.